All News
Basic Science highlights at #EULAR2024 @RheumNow https://t.co/gr3Mysp3f4
Bella Mehta bella_mehta ( View Tweet)
New validated BASDAI cut offs. BASDAI values of <2, <4 and >6 are often applied as cut-offs between remission, low (LDA), high (HDA) and very high (VHDA) disease activity, respectively, although this remains unvalidated. The optimal BASDAI values against external criteria were… https://t.co/5cvWoddHaN https://t.co/oBwYmFsIga
Links:
Dr. Antoni Chan synovialjoints ( View Tweet)
#EULAR2024 POS0234 The effect of prophylactic Septrin in ANCA #vasculitis pts treated with RTX/CyC need further characterisation. Multicentre study in Korea showed protective effect on Serious Infection btw those treated vs not. Effect was seen in the first 3mths only @RheumNow https://t.co/dCzD21589S
Md Yuzaiful Md Yusof Yuz6Yusof ( View Tweet)
#EULAR2024
Powerful quote to end @Dr_SBattista’s HPR highlights:
"People working together in a strong community with a shared goal and a common purpose can make the impossible possible"- Tom Vilsack
@RheumNow
Mrinalini Dey DrMiniDey ( View Tweet)
Interdisciplinary collaboration is the key!
@rheumnow #EULAR2024 https://t.co/pARPUH2ntr
Bella Mehta bella_mehta ( View Tweet)
Photos of hands/finger folds for RA disease activity - nice idea, challenges++, but with poor photo quality you’re always struggling.
Telehealth has taught us:
- ideal settings can work, but
- suboptimal inputs inevitably lead to suboptimal results
#EULAR2024 POS0451 @RheumNow https://t.co/fyCQzSl6tB
David Liew drdavidliew ( View Tweet)
placebo effects can be huge!
#EULAR2024 @RheumNow https://t.co/RmcBAPG2Ye
Links:
Bella Mehta bella_mehta ( View Tweet)
Fantastic speakers, chairs and faculty for the #PARE session on self-management.
#EULAR2024 @RheumNow https://t.co/9ulRWL2Mnp
Mrinalini Dey DrMiniDey ( View Tweet)
#EULAR2024 highlights
@Dr_SBattista discusses the beneficial effects of exercise for inflammation and general well-being, presented by Prof Kitas
@RheumNow https://t.co/WAHg4ub8R3
Mrinalini Dey DrMiniDey ( View Tweet)
Have RA and want to get pregnant? What can you do?
The answer is simple: disease control.
Implementing T2T in RA led to much better fertility. RA therapy is your friend!
#EULAR2024 POS0436 Rotterdam @RheumNow https://t.co/aoxNakMix1
Links:
David Liew drdavidliew ( View Tweet)
OP0007 (2024)
S/C ABA VS ADA H2H COMPARISON ADULTS EARLY, DUAL SEROPOSITIVE RA, +ive FOR SHARED EPITOPE HLA CLASS II RISK ALLELES, & INADEQUATE RESPONSE TO MTX: RESULTS FROM PH3 AMPLIFIED TRIAL shame seropositivity did not translate to an advantage for AbA @RheumNow #EULAR2024
Peter Nash drpnash ( View Tweet)
PARE summary at #EULAR2024 - love the word cloud highlighting the posters @RheumNow
RA, SLE and JIA were the key RMDs that were focused on. By Silvia Aguleria https://t.co/WbSKwE6vXs
Links:
Bella Mehta bella_mehta ( View Tweet)
#EULAR2024 POS0375 Negative trial need to be reported too. Phase 2 RCT of S95011, an IL7-R antibody in moderate to severe systemic #Sjogren failed to meet primary endpoint (ESSDAI) or other secondary (ESSPRI, biomarkers). This inhibition unlikely to impact on SjD @RheumNow
Md Yuzaiful Md Yusof Yuz6Yusof ( View Tweet)
EULAR PARE highlights
- Need close collaboration between patients and physicians.
-Child to adult transition need to be smooth to be successful (30% patients can be lost in transitions)
- We need patients to participate in Health Technology Assessment
@rheumnow #EULAR2024 https://t.co/50qFpRGXo2
Links:
Bella Mehta bella_mehta ( View Tweet)
Another proof (if needed) that controlling DA in RA is a very important preventive measure in RA!
179 pts
ILD newly developed 9.5%
progressed 12.3%
no change 74.9%
improved 4.5%
5.7% in the LDA group 28.0% non-LDA group (p=0.006)
@RheumNow #EULAR2024 POS0408 https://t.co/7DyXr5zdCM
Aurelie Najm AurelieRheumo ( View Tweet)
POS0061 (2024)
INTERCEPTION OF THE DEVELOPMENT OF RA BY 1-YEAR MTX IN ACPA-NEGATIVE ARTHRALGIA PATIENTS AT INCREASED RISK FOR RA: 4 YEAR RESULTS OF THE TREAT EARLIER TRIAL MTX reduced development of RA in high risk acpa neg pts https://t.co/XWnzuVMlbn @RheumNow #EULAR2024
Links:
Peter Nash drpnash ( View Tweet)
T2T strategy in RA during pregnancy improves time to procreate
Results PreCARA (T2T median DAS28CRP 2.33) vs. PARA median DAS28CRP 3.84)
median TTP 84d vs. 196d
TTP exceeded 12 months in 23% of PreCARA pts compared to 42% in the PARA pts.
@RheumNow #EULAR2024 POS0436 https://t.co/DfgEvvtCwR
Aurelie Najm AurelieRheumo ( View Tweet)
RISK OF NON-MELANOMA SKIN CANCER WITH TNFi AND OTHER bDMARDs IN PATIENTS WITH PSORIATIC ARTHRITIS: A SWEDISH AND DANISH COHORT STUDY- despite having minimal sun 25% increase NMSC TNFis vs other bDMARDs - skin checks ! @RheumNow #EULAR2024
Peter Nash drpnash ( View Tweet)
EULAR Abstract Archive
POS0894 (2024)
SAFETY OF UPADACITINIB ACROSS RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS, AND AXIAL SPONDYLOARTHRITIS ENCOMPASSING 15,000 PATIENT-YEARS OF CLINICAL TRIAL DATA
Reassuring 15000 pt yrs f/u RA PsA AS https://t.co/XWnzuVMlbn @RheumNow #EULAR2024
Links:
Peter Nash drpnash ( View Tweet)
lets put this bed now @RheumNow #EULAR https://t.co/r0SVoOk47O
Peter Nash drpnash ( View Tweet)